Canaccord Genuity Maintains a 'Buy' on Solazyme (SZYM); Q4 preview: Minding the Milestones
Tweet Send to a FriendGet Alerts SZYM Hot Sheet
Price: $11.14 +4.11%
Rating Summary:
11 Buy, 0 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
11 Buy, 0 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade SZYM Now!
Canaccord Genuity maintains a 'Buy' on Solazyme (NASDAQ: SZYM) price target of $19.00.
Analyst, John Quealy, said, "SZYM will report Q4/11 results on February 21 after the close (call at 4:30pm ET). We model revs/EPS at $15.0M/$(0.16) vs. consensus at $15.1M/$(0.16). We find financial results to be less meaningful than progress vs. key milestones (detailed on following page) at this point (third quarterly call post IPO)."
"We expect funded research partnership programs to continue to account for the majority of sales this quarter, with ramping Algenist sales driving increased product revenues. We look for additional progress finalizing feedstock/offtake contracts, including additional details on the Roquette European sales agreement for algal flour."
For an analyst ratings summary and ratings history on Solazyme click here. For more ratings news on Solazyme click here.
Shares of Solazyme closed at $12.18 yesterday, with a 52 week range of $7.68-$27.47.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, John Quealy, said, "SZYM will report Q4/11 results on February 21 after the close (call at 4:30pm ET). We model revs/EPS at $15.0M/$(0.16) vs. consensus at $15.1M/$(0.16). We find financial results to be less meaningful than progress vs. key milestones (detailed on following page) at this point (third quarterly call post IPO)."
"We expect funded research partnership programs to continue to account for the majority of sales this quarter, with ramping Algenist sales driving increased product revenues. We look for additional progress finalizing feedstock/offtake contracts, including additional details on the Roquette European sales agreement for algal flour."
For an analyst ratings summary and ratings history on Solazyme click here. For more ratings news on Solazyme click here.
Shares of Solazyme closed at $12.18 yesterday, with a 52 week range of $7.68-$27.47.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
- Jefferies Lifts Numbers on Diana Shipping (DSX) Post Q1
- Williams-Sonoma (WSM) Delivers 'Clean' Q1 Beat - Analyst
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
